Folgen
Alberto Gajofatto
Alberto Gajofatto
Bestätigte E-Mail-Adresse bei univr.it
Titel
Zitiert von
Zitiert von
Jahr
Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study
B Martire, R Rondelli, A Soresina, C Pignata, T Broccoletti, A Finocchi, ...
Clinical immunology 126 (2), 155-164, 2008
3772008
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
A Gajofatto, MD Benedetti
3002015
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
R Magliozzi, OW Howell, R Nicholas, C Cruciani, M Castellaro, ...
Annals of neurology 83 (4), 739-755, 2018
2432018
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
S Mariotto, S Ferrari, S Monaco, MD Benedetti, K Schanda, D Alberti, ...
Journal of neurology 264, 2420-2430, 2017
1492017
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015
S Monaco, S Mariotto, S Ferrari, M Calabrese, G Zanusso, A Gajofatto, ...
World Journal of Gastroenterology 21 (42), 11974, 2015
1352015
HCV-related nervous system disorders
S Monaco, S Ferrari, A Gajofatto, G Zanusso, S Mariotto
Journal of Immunology Research 2012, 2012
1342012
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosis
A Gajofatto, P Bacchetti, B Grimes, A High, E Waubant
Multiple Sclerosis Journal 15 (1), 50-58, 2009
1282009
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis
A Gajofatto, M Calabrese, MD Benedetti, S Monaco
Disease markers 35, 687-699, 2013
1102013
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
F Patti, S Messina, C Solaro, MP Amato, R Bergamaschi, S Bonavita, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 944-951, 2016
1092016
DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ...
Annals of clinical and translational neurology 8 (8), 1738-1744, 2021
1042021
Sensory integration balance training in patients with multiple sclerosis: a randomized, controlled trial
M Gandolfi, D Munari, C Geroin, A Gajofatto, MD Benedetti, A Midiri, ...
Multiple Sclerosis Journal 21 (11), 1453-1462, 2015
1032015
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study
G Farina, R Magliozzi, M Pitteri, R Reynolds, S Rossi, A Gajofatto, ...
Journal of neuroinflammation 14, 1-11, 2017
1022017
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases
S Mariotto, A Gajofatto, L Batzu, R Delogu, GP Sechi, S Leoni, MI Pirastru, ...
Neurology 93 (20), e1867-e1872, 2019
912019
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study
A Matinella, M Lanzafame, MA Bonometti, A Gajofatto, E Concia, S Vento, ...
Journal of Neurology 262, 1317-1327, 2015
902015
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score
P Invernizzi, L Bertolasi, MR Bianchi, M Turatti, A Gajofatto, MD Benedetti
Journal of neurology 258, 1933-1939, 2011
862011
Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes
A Farina, G Peruzzi, V Lacconi, S Lenna, S Quarta, E Rosato, AR Vestri, ...
Arthritis research & therapy 19, 1-14, 2017
812017
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients
M Calabrese, R Reynolds, R Magliozzi, M Castellaro, A Morra, A Scalfari, ...
PloS one 10 (8), e0135428, 2015
672015
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
M Di Filippo, C Cordioli, S Malucchi, P Annovazzi, P Cavalla, VT Clerici, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (4), 448-450, 2022
662022
Switching multiple sclerosis patients with breakthrough disease to second-line therapy
T Castillo-Trivino, EM Mowry, A Gajofatto, D Chabas, E Crabtree-Hartman, ...
PloS one 6 (2), e16664, 2011
662011
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases
A Gajofatto, S Monaco, M Fiorini, G Zanusso, M Vedovello, F Rossi, ...
Archives of neurology 67 (6), 724-730, 2010
622010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20